Multicenter evaluation of four methods for Clostridium difficile detection: ImmunoCard C-difficile, cytotoxin assay, culture, and latex agglutination

A three-center study was undertaken to compare several test methods for the detection of Clostridium difficile, associated toxin, or related markers by using 927 stool specimens, Methods included direct assay of cytotoxin in stool by tissue culture, C. difficile bacterial culture followed by cytotoxin assay, bacterial culture alone, latex agglutination assay, and the ImmunoCard C. difficile test (Meridian Diagnostics, Inc.), The sensitivities, as determined against direct cytotoxin assay results, of the ImmunoCard C. difficile and latex agglutination assays were 84 and 67%, respectively (92 and 77%, respectively, when adjusted for bacterial culture outcomes), Evaluation for C. difficile-associated disease (CDAD) among 864 patients was based on clinical criteria for antibiotic-associated diarrhea combined with laboratory evidence of toxin or toxin-producing C. difficile in stool specimens, The sensitivity of each test method for screening of CDAD was as follows: bacterial culture, 95%; culture with cytotoxin assay of isolates, 90%; ImmunoCard C. difficile test, 83%; cytotoxin assay 82%; and latex agglutination assay, 67% (P less than or equal to 0.05 versus all other methods), The standard deviations of the test sensitivity statistics between study sites were ranked as follows: cytotoxin assay (+/-3.1%) < ImmunoCard C. difficile test (+/-5.7%) < latex agglutination assay (+/-12.3%) < culture (+/-24.7%) < culture with cytotoxin assay (+/-28.0%). The data support the use of the ImmunoCard C. difficile test as an adjunct for the diagnosis of CDAD.